Published in:
Open Access
01-12-2015 | Research
Quantitative evaluation of the immunodeficiency of a mouse strain by tumor engraftments
Authors:
Wei Ye, Zhiwu Jiang, Guan-Xiong Li, Yiren Xiao, Simiao Lin, Yunxin Lai, Suna Wang, Baiheng Li, Bei Jia, Yin Li, Zhi-liang Huang, Jin Li, Fenglan Feng, Shuhua Li, Huihui Yao, Zixia Liu, Su Cao, Lin Xu, Yangqiu Li, Donghai Wu, Lingwen Zeng, Mei Zhong, Pentao Liu, Zhe-sheng Wen, Bing Xu, Yao Yao, Duanqing Pei, Peng Li
Published in:
Journal of Hematology & Oncology
|
Issue 1/2015
Login to get access
Abstract
Background
The mouse is an organism that is widely used as a mammalian model for studying human physiology or disease, and the development of immunodeficient mice has provided a valuable tool for basic and applied human disease research. Following the development of large-scale mouse knockout programs and genome-editing tools, it has become increasingly efficient to generate genetically modified mouse strains with immunodeficiency. However, due to the lack of a standardized system for evaluating the immuno-capacity that prevents tumor progression in mice, an objective choice of the appropriate immunodeficient mouse strains to be used for tumor engrafting experiments is difficult.
Methods
In this study, we developed a tumor engraftment index (TEI) to quantify the immunodeficiency response to hematologic malignant cells and solid tumor cells of six immunodeficient mouse strains and C57BL/6 wild-type mouse (WT).
Results
Mice with a more severely impaired immune system attained a higher TEI score. We then validated that the NOD-scid-IL2Rg−/− (NSI) mice, which had the highest TEI score, were more suitable for xenograft and allograft experiments using multiple functional assays.
Conclusions
The TEI score was effectively able to reflect the immunodeficiency of a mouse strain.